The DOI matches its Crossref record.
Opsonins: Their function, identity, and clinical significance
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examples of proteins known to enhance phagocytotic uptake include collectin molecules such as surfactant protein A (SP-A) and SP-D, as well as members of the complement cascade involved in wound healing.”
From Particle toxicology and health - where are we? (2019) · cites this paper as [126]
In the citing paper
“For example, it has long being recognised that certain proteins trigger recognition by phagocytic cells, leading to rapid clearance of NPs associated with these proteins, which are known as opsonins [126].”
From Particle toxicology and health - where are we? (2019) · cites this paper as [126]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 41
- Wood, 1951, Studies on the cellular immunology of acute bacterial infections, Harvey Lect., 47, 72
- Shin, 1968, Chemotactic and anaphylotoxic fragment cleaved from the fifth component of guinea pig complement, Science, 162, 361, 10.1126/science.162.3851.361 · DOI
- Ward, 1966, Further studies on the chemotactic factor of complement and its formation in vivo, Immunology, 11, 141
- Horwitz, 1971, Use of leukocyte chemotaxis in vitro to assay mediators generated by immune reactions, J. Immunol., 106, 649, 10.4049/jimmunol.106.3.649 · DOI
- Wright, 1903, An experimental investigation of the role of the blood fluids in connection with phagocytosis, Proc. R. Soc. Ser. B. Biol. Sci., 72, 357, 10.1098/rspl.1903.0062 · DOI
- Ward, 1933, An analysis of the opsonic and tropic action of normal and immune sera based on experiments with the pneumococcus, J. Exp. Med., 57, 527, 10.1084/jem.57.4.527 · DOI
- Slopek, 1962, The role of complement and natural antibodies in the process of phagocytosis, Arch. Immunol. Ther. Exp. (Warsz.), 10, 559
- Sterzl, 1964, The opsonic activity of complement in sera without antibody, Folia Microbiol. (Praha), 8, 240, 10.1007/BF02872588 · DOI
- Hirsch, 1964, Studies on heat labile opsonin in rabbit serum, J. Immunol., 92, 145, 10.4049/jimmunol.92.1.145 · DOI
- Wood, 1941, Studies on the mechanism of recovery in pneumococcal pneumonia. I. The action of type specific antibody upon the pulmonary lesion of experimentalpneumonia, J. Exp. Med., 73, 201, 10.1084/jem.73.2.201 · DOI
- Rowley, 1966, Number of molecules of antibody required to promote phagocytosis of one bacterium, Nature, 210, 496, 10.1038/210496a0 · DOI
- Biozzi, 1961, Measurement of the opsonic effect of normal and immune sera on the phagocytosis of Salmonella typhi by the reticuloendothelial system, J. Immunol., 87, 296, 10.4049/jimmunol.87.3.296 · DOI
- Smith, 1967, Comparison of the opsonic activity of gamma G and gamma M anti-proteus globulins, J. Immunol., 98, 336, 10.4049/jimmunol.98.2.336 · DOI
- Robbins, 1968, The isolation and biological activities of rabbit gamma M and gamma G anti-Salmonella typhimurium antibodies, J. Exp. Med., 128, 553
- Quie, 1968, Phagocytosis in subacute bacterial endocarditis: Localization of the primary opsonic site to the Fc fragment, J. Exp. Med., 128, 553, 10.1084/jem.128.4.553 · DOI
- Messner, 1970, Receptors for human gamma G globulin on human neutrophils, J. Clin. Invest., 49, 2165, 10.1172/JCI106435 · DOI
- Johnston, 1969, The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors, J. Exp. Med., 129, 1275, 10.1084/jem.129.6.1275 · DOI
- Lay, 1968, Receptors for complement on leukocytes, J. Exp. Med., 128, 991, 10.1084/jem.128.5.991 · DOI
- Huber, 1968, Human monocytes: Distinct receptor sites for the third component of complement and for immunoglobulin G, Science, 162, 1281, 10.1126/science.162.3859.1281 · DOI
- Smith, 1969, Heat labile opsonins to pneumococcus. I. Participation of complement, J. Exp. Med., 130, 1209, 10.1084/jem.130.6.1209 · DOI
- Winkelstein, 1972, Heat labile opsonins to pneumococcus. III. The participation of immunoglobulin and of the alternate pathway of C3 activation, J. Immunol., 108, 1681, 10.4049/jimmunol.108.6.1681 · DOI
- Shin, 1969, Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5, J. Exp. Med., 130, 1229, 10.1084/jem.130.6.1229 · DOI
- Jason, 1972, Human heat labile opsonins: Evidence for their mediation via the alternate pathway of complement activation, J. Immunol., 109, 26, 10.4049/jimmunol.109.1.26 · DOI
- Johnson, 1972, Opsonic activity in human serum deficient in C2, J. Immunol., 109, 141, 10.4049/jimmunol.109.1.141 · DOI
- Pillemer, 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science, 120, 279, 10.1126/science.120.3112.279 · DOI
- Marcus, 1971, An alternate complement pathway: C3 cleaving activity, not due to C4, 2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum: Relation to properdin, Proc. Natl. Acad. Sci. U. S. A., 68, 1351, 10.1073/pnas.68.6.1351 · DOI
- Ruddy, 1972, The complement system of man, N. Engl. J. Med., 287, 489, 10.1056/NEJM197209072871005 · DOI
- Forman, 1969, Impaired opsonic activity but normal phagocytosis in low-birth-weight infants, N. Engl. J. Med., 281, 926, 10.1056/NEJM196910232811704 · DOI
- McCracken, 1971, Leukocyte function and the development of opsonic and complement activity in the neonate, Am. J. Dis. Child., 121, 121
- Dossett, 1969, Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns, Pediatrics, 44, 49, 10.1542/peds.44.1.49 · DOI
- Robinson, 1966, Pneumococcal meningitis in sickle cell anemia, N. Engl. J. Med., 274, 1006, 10.1056/NEJM196605052741806 · DOI
- Winkelstein, 1968, Deficiency of pneumococcal serum opsonizing activity in sickle cell disease, N. Engl. J. Med., 279, 459, 10.1056/NEJM196808292790904 · DOI
- Robbins, 1965, Normal response of sickle cell anemia patients to immunization with Salmonella vaccines, J. Pediatr., 66, 877, 10.1016/S0022-3476(65)80062-2 · DOI
- Johnston, 1972, Deficient serum opsonins in sickle cell disease, Pediatr. Res., 6, 381
- Pearson, 1969, Functional asplenia in sickle cell anemia, N. Engl. J. Med., 291, 923, 10.1056/NEJM196910232811703 · DOI
- Shulkind, 1967, Effect of antibody upon clearance of I-125-labelled pneumococci by spleen and liver, Pediatr. Res., 1, 178, 10.1203/00006450-196705000-00004 · DOI
- Alper, 1970, Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3), N. Engl. J. Med., 282, 349, 10.1056/NEJM197002122820701 · DOI
- Alper, 1970, Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection, J. Clin. Invest., 49, 1975, 10.1172/JCI106417 · DOI
- Miller, 1969, A familial, plasma-associated defect of phagocytosis, Lancet, 2, 60
- Miller, 1970, A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5), N. Engl. J. Med., 282, 354, 10.1056/NEJM197002122820702 · DOI
- Jacobs, 1972, Fatal familial Lenier's disease: A deficiency of the opsonic activity of serum complement, Pediatrics, 49, 225, 10.1542/peds.49.2.225 · DOI
Cited by
Sorted by citations
Particle toxicology and health - where are we?
Riediker, M., Zink, D., Kreyling, W., Oberdörster, G., Elder, A., Graham, U., Lynch, I., Duschl, A., Ichihara, G., Ichihara, S., et al. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0302-8 · Cited by 237
Metadata
- Authors
- Winkelstein, J. A.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1973-05
- Volume
- 82
- Issue
- 5
- Pages
- 747-753
- ISSN
- 0022-3476
- Cited by
- 69
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review